---
category: news
title: "AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine"
excerpt: "Renovaro expects to start human trials in the second half of 2024. Our combined company unites renowned leaders in AI and immunotherapy to deliver transformative solutions across the cancer care continuum. I am honored to serve as CEO, bringing decades of ..."
publishedDateTime: 2023-10-02T17:10:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/ai-company-gedicube-and-renovaro-biosciences-sign-definitive-agreement-to-combine-1032670497"
webUrl: "https://markets.businessinsider.com/news/stocks/ai-company-gedicube-and-renovaro-biosciences-sign-definitive-agreement-to-combine-1032670497"
type: article
quality: 42
heat: 42
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI

secured: "CjyrnwtQ4cTOfL9uQ3Za7htfKgMToq1pE+HWnEba1Z23xakmovDujC/gGkg1Sg2m9km6YOvOq9EuCVmbQMlIxP0UTxEsNDBeZ/nPfp27H1w1A8LUOsPxNx1g9tUbKyI9TZGlobdQMugtJsGGShFvzmPL5oPGfFtxhhpr418IHZl2Bg8UokX33hjw3eerD+ZWWlQUf2ZiCgfhrKwmhlJNjqvTRJRTNCNz0iEhUabrBWJ9w8U1GNDNQ+VmX3FJnlFEw6q2wpmDnZKvxiaNO5PIWp2vz6iGNVEITejRmOpwkzJjLxSYWjrEu9uunEyJw7WnD6M77TtkfDMEYCNCVLo3IxagwXDUeHPlrbWibOA3ozc=;9yuPzi4Eor/vo+eMYxeE/A=="
---

